Navigation Links
High Cost Forces NHS To Reject Inhaled Insulin

Exubera, a new form of insulin that could revolutionize diabetic treatment has been rejected by the NHS on account of high cost. // The drug can be inhaled and provides an ideal alternative to the daily insulin injections taken by numerous diabetics, worldwide.

Patients with both Type 1 and Type 2 diabetes can use the new form of insulin. The annual cost associated with this form of insulin has been projected to be £1,100 per person. The main disadvantage of this insulin form is the high cost and the need for insulin injections in the night.

Exubera represents the first ever non-injected option for insulin therapy. Although the use of insulin for treatment for diabetes has been discovered as early as 1920s, no such non-injected option for insulin therapy has been developed until now. Daily injections are still the only form of treatment for more than 800, 000 people in Britain.

The European licensing has approved the new form of insulin. Although clinical trials have demonstrated that inhaled insulin is equally effective in controlling blood sugar levels, the draft guidance by the watchdog the National Institute for Health and Clinical Excellence for England and Wales was disappointing.

According to Charity Diabetes UK, such a medical breakthrough should not be restricted on the basis of cost and the new development should be accessible to everyone. 'Many people with diabetes will be deeply disappointed that they are being denied this alternative form of treatment. There is an urgent need for more research to support the improvements made by using inhaled insulin on quality of life,' said a spokesperson for the organization.

'NICE has dismissed the robust scientific and medical evidence used by international medical experts in the US and Europe to grant widespread approval for this medicine. The choice here is quite simple: force patients to keep enduring the burden of multiple daily injections and poor com pliance, as they have since the 1920s, or give them an alternative,' responded Pfizer, a leading pharmaceutical that had manufactured the drug.

As the guidance issued by NICE has not been finalized, the general public and health care professionals have been urged to voice their opinion regarding the issue, before a final statement is published in October.

'Our review of the evidence indicated that inhaled insulin should not be recommended because it could not be proven to be more clinically or cost effective than existing treatments. The clinical experts we asked advised us that using injected insulin is not usually a concern for the majority of people with diabetes,' said Andrea Sutcliffe, deputy chief executive at NICE and executive lead for the appraisal.


Related medicine news :

1. A Joint Venture by Golfers And Military Forces To Combat AIDS
2. Lunar Forces Affect The Surface Of The Earth
3. Patient Safety Forces Closure Of Hospital
4. Massive Culling Of Poultry Forces Farm Owner To Commit Suicide
5. New Government Contract Forces Dentists To Quit The NHS
6. Incidence Of HIV/AIDS In The Indian Armed Forces Negligible
7. Malaria Epidemic Forces Assam Rebels Out Of The Jungle
8. INS ASHVINI Bags Trophy For Best Armed Forces Hospital
9. City Surgeon Appointed Adviser To Armed Forces
10. Girl Students Sexually Harassed by Security Forces in Nepal
11. NHS Debts Forces Hewitt to Consider Resignation
Post Your Comments:

(Date:11/25/2015)... , ... November 25, 2015 , ... ... has focused on providing comprehensive solutions involving adult stem cell therapies to patients ... officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are ...
(Date:11/25/2015)... ... 25, 2015 , ... Bunion Bootie , the newest ... of the early holiday shopping season. Starting Wednesday November 25th, Bunion Booties are ... Friday promotional pricing is in addition to any automatic discounts applied when buying ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. Seidel, ... many benefits of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser ... used by a dentist in Gettysburg, PA . From routine visits to ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
(Date:11/24/2015)... 25, 2015 WuXi PharmaTech (Cayman) Inc. ("WuXi" ... open-access R&D capability and technology platform company serving the ... China and the ... extraordinary general meeting of shareholders held today, the Company,s ... and approve the previously announced agreement and plan of ...
(Date:11/24/2015)... N.C. , Nov. 24, 2015  In the ... projects in an effort to quickly uncover new insights, ... --> --> However, ... a market research project and ensure that all rules ... and industry standards. Another major barrier to efficiently launching ...
Breaking Medicine Technology: